Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Diabetes and Endocrine Centre, Mater Dei Hospital, Msida, Malta.
Curr Obes Rep. 2021 Sep;10(3):263-273. doi: 10.1007/s13679-021-00435-z. Epub 2021 May 8.
The aim of this review is to outline the obesity physician's role in managing patients with severe obesity with a particular emphasis on bariatric surgery candidates.
Obesity is a chronic, relapsing and progressive disease. Scoring systems that evaluate the severity of obesity based on the clinical assessment, rather than the Body Mass Index, are a valuable tool. The clinical assessment should explore the underlying contributors for weight gain and screen for obesity-related complications. Bariatric surgery remains the most effective management approach for severe and complex obesity. Nevertheless, pharmacotherapy and other non-surgical approaches play an important role. The bariatric-metabolic physician's role is paramount in delivering effective care to patients with obesity. The multiple complications of patients with clinically severe obesity highlight the complexity of their management and reinforce the need for adequate assessment and long-term follow-up to ensure optimal clinical outcomes.
本文旨在概述肥胖症医生在管理重度肥胖患者中的作用，尤其侧重于肥胖症患者接受减重手术的情况。
肥胖是一种慢性、复发性和进行性疾病。基于临床评估而不是体重指数（BMI）来评估肥胖严重程度的评分系统是一种有价值的工具。临床评估应探讨体重增加的潜在原因，并筛查肥胖相关并发症。减重手术仍然是治疗严重和复杂肥胖的最有效方法。然而，药物治疗和其他非手术方法也起着重要作用。减重代谢医师在为肥胖症患者提供有效治疗方面发挥着至关重要的作用。患有临床重度肥胖症的患者存在多种并发症，这突显了其管理的复杂性，并强调了进行充分评估和长期随访以确保最佳临床结果的必要性。
